Dorsey Wright & Associates Acquires Shares of 3,025 HCA Healthcare, Inc. $HCA

Dorsey Wright & Associates bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 3,025 shares of the company’s stock, valued at approximately $1,432,000.

A number of other large investors have also recently added to or reduced their stakes in the stock. Sumitomo Life Insurance Co. raised its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares in the last quarter. MJP Associates Inc. ADV grew its stake in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC raised its stake in HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares in the last quarter. Anchyra Partners LLC grew its position in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd raised its position in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Cantor Fitzgerald dropped their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday. Argus decreased their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Wells Fargo & Company dropped their price target on HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th. Finally, Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $486.14.

HCA Healthcare Trading Down 3.7%

Shares of NYSE HCA opened at $371.60 on Friday. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The company has a market cap of $82.44 billion, a PE ratio of 12.78, a P/E/G ratio of 1.27 and a beta of 1.12. The stock has a 50 day simple moving average of $392.25 and a 200-day simple moving average of $457.05.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business posted $6.45 EPS. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 29.74 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.